|
ZNF16 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.421300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.392420E-02 |
| Normal-vs-Stage2 |
1.695650E-03 |
| Normal-vs-Stage3 |
9.65939999999499E-05 |
| Normal-vs-Stage4 |
1.398280E-03 |
| Stage1-vs-Stage2 |
1.377020E-01 |
| Stage1-vs-Stage3 |
3.267500E-02 |
| Stage1-vs-Stage4 |
1.511010E-01 |
| Stage2-vs-Stage3 |
9.167000E-01 |
| Stage2-vs-Stage4 |
8.209200E-01 |
| Stage3-vs-Stage4 |
6.964000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.171560E-04 |
| Normal-vs-AfricanAmerican |
1.886650E-01 |
| Normal-vs-Asian |
3.292500E-02 |
| Caucasian-vs-AfricanAmerican |
3.150600E-01 |
| Caucasian-vs-Asian |
5.145800E-01 |
| AfricanAmerican-vs-Asian |
3.707000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.159940E-04 |
| Normal-vs-Female |
1.508280E-02 |
| Male-vs-Female |
1.856450E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.613900E-02 |
| Normal-vs-Age(41-60Yrs) |
8.033300E-04 |
| Normal-vs-Age(61-80Yrs) |
3.843800E-04 |
| Normal-vs-Age(81-100Yrs) |
4.751600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.686400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.561400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.192800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.344000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.405200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.809000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.369400E-01 |
| Normal-vs-Grade 2 |
7.759900E-02 |
| Normal-vs-Grade 3 |
2.26539999998998E-05 |
| Normal-vs-Grade 4 |
5.03249997230171E-09 |
| Grade 1-vs-Grade 2 |
1.544440E-01 |
| Grade 1-vs-Grade 3 |
4.313600E-02 |
| Grade 1-vs-Grade 4 |
1.018140E-02 |
| Grade 2-vs-Grade 3 |
2.340500E-03 |
| Grade 2-vs-Grade 4 |
3.43900000032704E-07 |
| Grade 3-vs-Grade 4 |
1.388200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.921220E-01 |
| Normal-vs-ccB subtype |
8.13129999999163E-07 |
| ccA subtype-vs-ccB subtype |
1.67514999999119E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.47139999999657E-05 |
| Normal-vs-N1 |
7.980300E-04 |
| N0-vs-N1 |
2.556400E-01 |
|
|
